196 related articles for article (PubMed ID: 15725964)
1. Medication-associated somnambulism.
Lange CL
J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):211-2. PubMed ID: 15725964
[No Abstract] [Full Text] [Related]
2. Zolpidem tartrate and somnambulism.
Harazin J; Berigan TR
Mil Med; 1999 Sep; 164(9):669-70. PubMed ID: 10495642
[TBL] [Abstract][Full Text] [Related]
3. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
Lee SI; Keltner NL
Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
[No Abstract] [Full Text] [Related]
4. Writing emails as part of sleepwalking after increase in Zolpidem.
Siddiqui F; Osuna E; Chokroverty S
Sleep Med; 2009 Feb; 10(2):262-4. PubMed ID: 19059805
[No Abstract] [Full Text] [Related]
5. Venlafaxine-induced excessive yawning.
Chen CH; Lu ML
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):156-7. PubMed ID: 19000733
[No Abstract] [Full Text] [Related]
6. Dosing by side effect threshold: two cases of panic disorder responsive to low-dose venlafaxine.
Orenstein H; Raskind MA
J Clin Psychiatry; 2010 Jan; 71(1):89-91. PubMed ID: 20129010
[No Abstract] [Full Text] [Related]
7. Sertraline versus venlafaxine XR in major depressive disorder.
Lusicic A; Jagadheesan K
J Clin Psychiatry; 2007 Oct; 68(10):1618-9; author reply 1619. PubMed ID: 17960983
[No Abstract] [Full Text] [Related]
8. A possible case of venlafaxine-induced Stevens-Johnson syndrome.
Weiss NT; Jones L; Chamberlain JC
J Clin Psychiatry; 2004 Oct; 65(10):1431-3. PubMed ID: 15491252
[No Abstract] [Full Text] [Related]
9. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
[TBL] [Abstract][Full Text] [Related]
10. Combined oral venlafaxine and intravenous clomipramine-A: successful temporary response in a patient with extremely refractory depression.
Fountoulakis KN; Iacovides A; St Kaprinis G
Can J Psychiatry; 2004 Jan; 49(1):73-4. PubMed ID: 14763683
[No Abstract] [Full Text] [Related]
11. One rare side effect of zolpidem--sleepwalking: a case report.
Yang W; Dollear M; Muthukrishnan SR
Arch Phys Med Rehabil; 2005 Jun; 86(6):1265-6. PubMed ID: 15954071
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of extended-release venlafaxine in severe medical and surgical illness.
Schwartz T; Jindal S; Virk S; Wade M
Psychosomatics; 2004; 45(3):217-9. PubMed ID: 15123846
[TBL] [Abstract][Full Text] [Related]
13. A case of high-dose venlafaxine-related psychosis.
Dennison EA; Raidoo BM; Cruz R; Raidoo D
J Clin Psychopharmacol; 2013 Feb; 33(1):134-6. PubMed ID: 23288238
[No Abstract] [Full Text] [Related]
14. Successful duloxetine use to prevent venlafaxine withdrawal symptoms.
Hsiao MC; Liu CY
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):576. PubMed ID: 17889418
[No Abstract] [Full Text] [Related]
15. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Al-Adwani A
Can J Psychiatry; 2005 Nov; 50(13):877; author reply 877-8. PubMed ID: 16483124
[No Abstract] [Full Text] [Related]
16. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
17. Venlafaxine and treatment-resistant depression.
Thase ME; Friedman ES; Howland RH
Depress Anxiety; 2000; 12 Suppl 1():55-62. PubMed ID: 11098415
[TBL] [Abstract][Full Text] [Related]
18. Serotonin reuptake inhibitors in Raynaud's phenomenon.
Jaffe IA
Lancet; 1995 May; 345(8961):1378. PubMed ID: 7752794
[No Abstract] [Full Text] [Related]
19. [Sleep-walking linked to zolpidem].
Yanes Baonza M; Ferrer García-Borrás JM; Cabrera Majada A; Sánchez González R
Aten Primaria; 2003 Oct; 32(7):438. PubMed ID: 14622563
[No Abstract] [Full Text] [Related]
20. Safety and tolerability of the new antidepressants.
Nelson JC
J Clin Psychiatry; 1997; 58 Suppl 6():26-31. PubMed ID: 9227670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
